Evaluation of Plasma Lysophospholipids for Diagnostic Significance Using Electrospray Ionization Mass Spectrometry (ESI‐MS) Analyses
暂无分享,去创建一个
Y Chen | Yan Xu | J Belinson | J. Belinson | Y Xiao | A W Kennedy | Y Xu | A. Kennedy | Y. Chen | Yijin Xiao
[1] S. Tanaka,et al. Lysophosphatidic acids induce proliferation of cultured vascular smooth muscle cells from rat aorta. , 1994, The American journal of physiology.
[2] R. Miledi,et al. A factor that activates oscillatory chloride currents in Xenopus oocytes copurifies with a subfraction of serum albumin. , 1991, The Journal of biological chemistry.
[3] R. Miledi,et al. Lysophosphatidates bound to serum albumin activate membrane currents in Xenopus oocytes and neurite retraction in PC12 pheochromocytoma cells. , 1992, The Journal of biological chemistry.
[4] E. Lapetina,et al. Decanoyl lysophosphatidic acid induces platelet aggregation through an extracellular action. Evidence against a second messenger role for lysophosphatidic acid. , 1985, The Biochemical journal.
[5] R. Bast,et al. The CA 125 tumour-associated antigen: a review of the literature. , 1989, Human reproduction.
[6] R. Bast,et al. Reactivity of a monoclonal antibody with human ovarian carcinoma. , 1981, The Journal of clinical investigation.
[7] A. Tuininga,et al. Isoprenoid-mediated changes in the glycerophospholipid molecular species of the sterol auxotrophic fungus Lagenidium giganteum. , 1995, Microbiology.
[8] Xianlin Han,et al. Electrospray ionization mass spectroscopic analysis of human erythrocyte plasma membrane phospholipids. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[9] S. Weintraub,et al. Electrospray ionization for analysis of platelet-activating factor. , 1991, Rapid Communications in Mass Spectrometry.
[10] G. Mills,et al. Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.
[11] Y. Oda,et al. Simultaneous quantitative determination method for sphingolipid metabolites by liquid chromatography/ionspray ionization tandem mass spectrometry. , 1997, Analytical biochemistry.
[12] W. Collins,et al. SCREENING FOR EARLY OVARIAN CANCER , 1988, The Lancet.
[13] W. Creasman,et al. Ovarian cancer screening. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] M Markman,et al. Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers. , 1998, JAMA.
[15] M. Palmer,et al. WHO Handbook for Reporting Results of Cancer Treatment , 1982, British Journal of Cancer.
[16] G. Mills,et al. Lysophospholipids activate ovarian and breast cancer cells. , 1995, The Biochemical journal.
[17] M. Triggiani,et al. Antigen-induced generation of lyso-phospholipids in human airways , 1996, The Journal of experimental medicine.
[18] Wei Sha,et al. Structural Identification by Mass Spectrometry of Oxidized Phospholipids in Minimally Oxidized Low Density Lipoprotein That Induce Monocyte/Endothelial Interactions and Evidence for Their Presence in Vivo * , 1997, The Journal of Biological Chemistry.
[19] R. Bast,et al. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. , 1983, The New England journal of medicine.
[20] I. Fahrenfort,et al. The bioactive phospholipid lysophosphatidic acid is released from activated platelets. , 1993, The Biochemical journal.
[21] A. Karlsson,et al. Molecular species of sphingomyelin: determination by high-performance liquid chromatography/mass spectrometry with electrospray and high-performance liquid chromatography/tandem mass spectrometry with atmospheric pressure chemical ionization. , 1998, Journal of mass spectrometry : JMS.
[22] J. Turk,et al. Electrospray ionization mass spectrometric analyses of phospholipids from rat and human pancreatic islets and subcellular membranes: comparison to other tissues and implications for membrane fusion in insulin exocytosis. , 1998, Biochemistry.
[23] C. Hoischen,et al. Structural characterization of molecular phospholipid species in cytoplasmic membranes of the cell wall-less Streptomyces hygroscopicus L form by use of electrospray ionization coupled with collision-induced dissociation mass spectrometry , 1997, Journal of bacteriology.
[24] B. Karlan,et al. Early detection and risk reduction for familial gynecologic cancers. , 1998, Clinical obstetrics and gynecology.
[25] R. Gross,et al. Alterations in individual molecular species of human platelet phospholipids during thrombin stimulation: electrospray ionization mass spectrometry-facilitated identification of the boundary conditions for the magnitude and selectivity of thrombin-induced platelet phospholipid hydrolysis. , 1996, Biochemistry.
[26] G. Mills,et al. Elevated levels and altered fatty acid composition of plasma lysophosphatidlycholine(lysoPC) in ovarian cancer patients , 1997, International journal of cancer.
[27] F. Hsu,et al. Formation of lithiated adducts of glycerophosphocholine lipids facilitates their identification by electrospray ionization tandem mass spectrometry , 1998, Journal of the American Society for Mass Spectrometry.
[28] A. Tuininga,et al. Identification of molecular species of glycerophospholipids and sphingomyelin using electrospray mass spectrometry. , 1994, Journal of lipid research.
[29] J. Kerwin,et al. Identification of fatty acids by electrospray mass spectrometry and tandem mass spectrometry. , 1996, Journal of mass spectrometry : JMS.
[30] R. Bast,et al. Elevation of multiple serum markers in patients with stage I ovarian cancer. , 1993, Journal of the National Cancer Institute.
[31] R. Bast,et al. Ovarian cancer screening. The use of serial complementary tumor markers to improve sensitivity and specificity for early detection , 1995, Cancer.
[32] P. Schwartz,et al. Is early detection of ovarian cancer possible? , 1995, Annals of medicine.